AIM OF THE STUDY: The aerial parts of Baccharis dracunculifolia D.C., popularly known as "alecrim do campo", are used in folk medicine as anti-inflammatory. The aim of the present study was to evaluate the anti-inflammatory and antinociceptive activities of the crude hydroalcoholic extract obtained from leaves of Baccharis dracunculifolia (BdE), which have not been reported. MATERIALS AND METHODS: BdE was analyzed by HPLC and in vivo evaluated (doses ranging from 50 to 400mg/kg, p.o.) by using the acetic acid-induced abdominal constrictions, paw oedema induced by carrageenan or histamine, overt nociception models using capsaicin, glutamate or phorbol myristate acetate (PMA), formalin-induced nociception and mechanical hypernociception induced by carrageenan or complete Freund adjuvant (CFA). As positive controls it was used paracetamol in both acetic acid and formalin tests; dipyrone in capsaicin, glutamate and PMA-induced nociception; indomethacin in CFA and carrageenan-induced hypernociception models. In addition, the in vitro effects of BdE on COX-2 activity and on the activation of NF-kappaB were also evaluated. RESULTS: BdE (50-400mg/kg, p.o.) significantly diminished the abdominal constrictions induced by acetic acid, glutamate and CFA. Furthermore, BdE also inhibited the nociceptive responses in both phases of formalin-induced nociception. BdE, administered orally, also produced a long-lasting anti-hypernociceptive effect in the acute model of inflammatory pain induced by carrageenan. It was also observed the inhibition of COX-2 activity by BdE. CONCLUSION: In summary, the data reported in this work confirmed the traditional anti-inflammatory indications of Baccharis dracunculifolia leaves and provided biological evidences that Baccharis dracunculifolia, like Brazilian green propolis, possess antinociceptive and anti-inflammatory activities. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
AIM OF THE STUDY: The aerial parts of Baccharis dracunculifolia D.C., popularly known as "alecrim do campo", are used in folk medicine as anti-inflammatory. The aim of the present study was to evaluate the anti-inflammatory and antinociceptive activities of the crude hydroalcoholic extract obtained from leaves of Baccharis dracunculifolia (BdE), which have not been reported. MATERIALS AND METHODS: BdE was analyzed by HPLC and in vivo evaluated (doses ranging from 50 to 400mg/kg, p.o.) by using the acetic acid-induced abdominal constrictions, paw oedema induced by carrageenan or histamine, overt nociception models using capsaicin, glutamate or phorbol myristate acetate (PMA), formalin-induced nociception and mechanical hypernociception induced by carrageenan or complete Freund adjuvant (CFA). As positive controls it was used paracetamol in both acetic acid and formalin tests; dipyrone in capsaicin, glutamate and PMA-induced nociception; indomethacin in CFA and carrageenan-induced hypernociception models. In addition, the in vitro effects of BdE on COX-2 activity and on the activation of NF-kappaB were also evaluated. RESULTS: BdE (50-400mg/kg, p.o.) significantly diminished the abdominal constrictions induced by acetic acid, glutamate and CFA. Furthermore, BdE also inhibited the nociceptive responses in both phases of formalin-induced nociception. BdE, administered orally, also produced a long-lasting anti-hypernociceptive effect in the acute model of inflammatory pain induced by carrageenan. It was also observed the inhibition of COX-2 activity by BdE. CONCLUSION: In summary, the data reported in this work confirmed the traditional anti-inflammatory indications of Baccharis dracunculifolia leaves and provided biological evidences that Baccharis dracunculifolia, like Brazilian green propolis, possess antinociceptive and anti-inflammatory activities. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: Juliane C Silva; Camila de S Araújo; Sarah Raquel G de Lima-Saraiva; Raimundo G de Oliveira-Junior; Tâmara C Diniz; Carlos Wagner de S Wanderley; Raimundo C Palheta-Júnior; Rosemairy L Mendes; Adriana G Guimarães; Lucindo J Quintans-Júnior; Jackson Roberto G da S Almeida Journal: BMC Complement Altern Med Date: 2015-06-24 Impact factor: 3.659
Authors: Juliane Cabral Silva; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Juliana Mikaelly Dias Soares; Sarah Raquel Gomes de Lima-Saraiva; Tâmara Coimbra Diniz; Rosemairy Luciane Mendes; Edilson Beserra de Alencar Filho; Eliezer Jesus de Lacerda Barreiro; Lídia Moreira Lima; Jackson Roberto Guedes da Silva Almeida Journal: PLoS One Date: 2018-07-30 Impact factor: 3.240
Authors: Eric Woode; Ama Kyeraa Amoh-Barimah; Wonder Kofi Mensah Abotsi; George Kwaw Ainooson; George Owusu Journal: Indian J Pharmacol Date: 2012 Nov-Dec Impact factor: 1.200
Authors: Izaque S Maciel; Rodrigo B M Silva; Fernanda B Morrone; João B Calixto; Maria M Campos Journal: PLoS One Date: 2013-09-27 Impact factor: 3.240
Authors: Sidra Khalid; Muhammad Z Ullah; Ashraf U Khan; Ruqayya Afridi; Hina Rasheed; Adnan Khan; Hussain Ali; Yeong S Kim; Salman Khan Journal: Front Pharmacol Date: 2018-03-20 Impact factor: 5.810